chr16-1215608-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_021098.3(CACNA1H):c.5244+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,605,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.711
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-1215608-C-T is Benign according to our data. Variant chr16-1215608-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2924225.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 27 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.5244+15C>T | intron_variant | Intron 30 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
CACNA1H | ENST00000565831.6 | c.5226+15C>T | intron_variant | Intron 28 of 32 | 1 | ENSP00000455840.1 | ||||
CACNA1H | ENST00000638323.1 | c.5205+15C>T | intron_variant | Intron 30 of 34 | 5 | ENSP00000492267.1 | ||||
CACNA1H | ENST00000569107.5 | c.1482+15C>T | intron_variant | Intron 12 of 16 | 1 | ENSP00000454990.2 | ||||
CACNA1H | ENST00000564231.5 | c.1467+15C>T | intron_variant | Intron 13 of 17 | 1 | ENSP00000457555.2 | ||||
CACNA1H | ENST00000562079.5 | c.1449+15C>T | intron_variant | Intron 12 of 16 | 1 | ENSP00000454581.2 | ||||
CACNA1H | ENST00000639478.1 | n.*325+15C>T | intron_variant | Intron 30 of 34 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*3095+15C>T | intron_variant | Intron 30 of 34 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
2
AN:
152228
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000298 AC: 7AN: 234652Hom.: 0 AF XY: 0.0000312 AC XY: 4AN XY: 128222
GnomAD3 exomes
AF:
AC:
7
AN:
234652
Hom.:
AF XY:
AC XY:
4
AN XY:
128222
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1453424Hom.: 0 Cov.: 34 AF XY: 0.0000235 AC XY: 17AN XY: 722576
GnomAD4 exome
AF:
AC:
27
AN:
1453424
Hom.:
Cov.:
34
AF XY:
AC XY:
17
AN XY:
722576
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152346Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74488
GnomAD4 genome
AF:
AC:
2
AN:
152346
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at